Ballentine Partners’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-1,393
| Closed | -$247K | – | 394 |
|
|
2020
Q1 | $247K | Buy |
1,393
+241
| +21% | +$42.7K | 0.01% | 281 |
|
|
2019
Q4 | $220K | Buy |
+1,152
| New | +$220K | 0.01% | 356 |
|
|
2018
Q2 | – | Sell |
-1,624
| Closed | -$273K | – | 376 |
|
|
2018
Q1 | $273K | Sell |
1,624
-673
| -29% | -$113K | 0.02% | 265 |
|
|
2017
Q4 | $376K | Sell |
2,297
-367
| -14% | -$60.1K | 0.02% | 230 |
|
|
2017
Q3 | $546K | Buy |
2,664
+295
| +12% | +$60.5K | 0.03% | 180 |
|
|
2017
Q2 | $598K | Sell |
2,369
-506
| -18% | -$128K | 0.04% | 173 |
|
|
2017
Q1 | $688K | Buy |
2,875
+142
| +5% | +$34K | 0.05% | 97 |
|
|
2016
Q4 | $579K | Sell |
2,733
-1,969
| -42% | -$417K | 0.04% | 94 |
|
|
2016
Q3 | $1.08M | Buy |
4,702
+3,624
| +336% | +$835K | 0.09% | 54 |
|
|
2016
Q2 | $249K | Sell |
1,078
-379
| -26% | -$87.5K | 0.02% | 170 |
|
|
2016
Q1 | $392K | Buy |
1,457
+133
| +10% | +$35.8K | 0.03% | 132 |
|
|
2015
Q4 | $414K | Buy |
1,324
+112
| +9% | +$35K | 0.04% | 108 |
|
|
2015
Q3 | $329K | Buy |
1,212
+24
| +2% | +$6.52K | 0.03% | 118 |
|
|
2015
Q2 | $360K | Sell |
1,188
-14
| -1% | -$4.24K | 0.04% | 118 |
|
|
2015
Q1 | $358K | Buy |
1,202
+65
| +6% | +$19.4K | 0.04% | 116 |
|
|
2014
Q4 | $293K | Hold |
1,137
| – | – | 0.03% | 125 |
|
|
2014
Q3 | $274K | Buy |
+1,137
| New | +$274K | 0.03% | 118 |
|